Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
about
Progressive familial intrahepatic cholestasisEstrogen and Estrogen Receptor-α-Mediated Transrepression of Bile Salt Export PumpPolymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variabilityBile acid transporters in health and diseaseBile acid transportersMissense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicingFXR regulates liver repair after CCl4-induced toxic injuryDetergent screening and purification of the human liver ABC transporters BSEP (ABCB11) and MDR3 (ABCB4) expressed in the yeast Pichia pastorisGenetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian CenterATP8B1 is essential for maintaining normal hearingMechanistic insights into isoform-dependent and species-specific regulation of bile salt export pump by farnesoid X receptor.Variations in the G6PC2/ABCB11 genomic region are associated with fasting glucose levels.Progressive familial intrahepatic cholestasis.Clinical application of transcriptional activators of bile salt transporters.Bile formation and secretion.Early Diagnosis of ABCB11 Spectrum Liver Disorders by Next Generation SequencingDiagnosis of ABCB11 gene mutations in children with intrahepatic cholestasis using high resolution melting analysis and direct sequencing.Medical treatment of cholestatic liver diseases: From pathobiology to pharmacological targets.ApoB-100, ApoE and CYP7A1 gene polymorphisms in Mexican patients with cholesterol gallstone disease.Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma.The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver diseaseDifferences in presentation and progression between severe FIC1 and BSEP deficiencies.Gallstone disease.Human cardiovascular disease IBC chip-wide association with weight loss and weight regain in the look AHEAD trial.Description of two new ABCB11 mutations responsible for type 2 benign recurrent intrahepatic cholestasis in a French-Canadian familyGenetics of familial intrahepatic cholestasis syndromes.The APOB gene polymorphism in the pathogenesis of gallstone disease in pre- and postmenopausal women.Systems pharmacology modeling predicts delayed presentation and species differences in bile acid-mediated troglitazone hepatotoxicityApproach to a patient with elevated serum alkaline phosphatase.The Features of GGT in Patients with ATP8B1 or ABCB11 Deficiency Improve the Diagnostic Efficiency.Hepatobiliary transport in health and diseaseMechanisms of disease: the genetic epidemiology of gallbladder stones.FXR: a target for cholestatic syndromes?FXR and PXR: potential therapeutic targets in cholestasis.Endoscopic nasobiliary drainage improves jaundice attack symptoms in benign recurrent intrahepatic cholestasis: A case report.Prediction of drug-induced intrahepatic cholestasis: in vitro screening and QSAR analysis of drugs inhibiting the human bile salt export pump.Increased Bile Acid Synthesis and Impaired Bile Acid Transport in Human Obesity.Genetic factors in the pathogenesis of cholangiocarcinomaRole of polymorphic bile salt export pump (BSEP, ABCB11) transporters in anti-tuberculosis drug-induced liver injury in a Chinese cohort.Congenital cholestatic syndromes: what happens when children grow up?
P2860
Q21202893-B23B091B-3F84-4B9D-9306-C80D18A03FFBQ24318914-CC4456A4-D7B8-4811-9974-66364F236CD5Q24596022-D2ADF10D-0D6F-4497-800E-200436E9EDAAQ24647024-EE643823-C8AE-4361-B11B-94DE3E0AFD7AQ24652624-48468445-B0F1-4AE2-A393-B37F17776E74Q28304808-01A605D8-C867-4679-B4A3-061CAFFA472BQ28396872-D0351B8F-FE40-4426-A823-87C31DF94637Q28485995-04DA73C9-7976-4C2D-8183-26B477CD603AQ28551572-D778DE6E-7066-421A-B718-E50D7897650EQ28593592-CD4BDE7D-35B3-4AF8-90CF-4A9D1496696FQ30409833-6687F29B-DF50-4A85-9F4D-D5BA1DEFDB40Q30441439-89F85947-2A3C-451C-901A-4A6F6728A927Q33595403-A6C56C95-C4C5-48A3-A2E1-7A10CB8B37A6Q33709930-9A1CBCF6-7A8D-4F99-90A9-8FE9D0DA6E49Q33881922-AA7BF305-23A5-4C69-BFEB-1D972D60D34FQ33918254-E779F4D3-E435-4781-A226-F54D0132C115Q34000592-48ADA824-C1D0-48A1-B568-14DF8AEA7B96Q34017604-A718A672-E295-4355-89A6-82AAE53B2190Q34183183-06A6D1DE-BA42-431D-B873-7B002863EB9BQ34224637-648CF2FF-BA3A-4F2D-9743-B42A58211260Q34432666-90C2FFEA-74A3-4E35-9215-4DEC392E9126Q34592094-B629FA6F-D8DC-48FC-B13E-A0161A67474CQ34634193-81B14BA8-7B1D-41A5-92AF-4B920FBE9DE3Q34641723-81526DDB-F03A-4E87-A754-06C58B9F02FFQ35124972-1429836E-6F9D-4673-B810-E7C2FF0A6AF1Q35448570-9A84C908-2C27-4A95-B6ED-7C74123022EDQ35632508-EC51DAFE-D839-45A4-BEBD-CF280CD64C23Q35781894-3955BB11-F81C-4E2A-8630-CF630FFCAE4FQ35926418-B9D1E65D-1700-4A88-AF61-635CF9E2226EQ35981086-BAA5FD4F-1316-4132-B790-05630C4D3B62Q36126750-D4784095-2665-4DBC-BE78-152AD8DACA0CQ36304268-260F0843-2606-48D0-9D25-B61CE3B6B652Q36481061-16F9AE16-6F16-48CB-A228-814B075C3248Q36572561-03B0142B-F11E-43F5-8619-DCB3C35A2687Q36603612-D07DEB6F-B014-411A-BB45-4718BF2B98A8Q36689081-12F3178A-4C27-480A-A334-2DFD0B718371Q36911455-330F311E-07F7-4AFE-8C54-E62919EEE8B2Q36966040-49114644-5BBF-451F-ACE4-DD8669425207Q36996132-C4C532DA-7F2C-415F-AC78-93690D6D35A8Q37008383-501F01B5-D49E-429D-9BF9-7A00E4ADE9E0
P2860
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@ast
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@en
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@nl
type
label
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@ast
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@en
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@nl
prefLabel
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@ast
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@en
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@nl
P2093
P3181
P1433
P1476
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11
@en
P2093
Ekkehard Sturm
Gerda van der Brugge
Inge E T van den Berg
Laura N Bull
Leo W J Klomp
Peter L M Jansen
Roderick H J Houwen
Ruud Berger
Saskia W C van Mil
Wendy L van der Woerd
P304
P3181
P356
10.1053/J.GASTRO.2004.04.065
P407
P577
2004-08-01T00:00:00Z